KATHLEEN BROWN: Open Payments
NPI 1689910929 · RIVERHEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,639 in 57 payments from 13 companies in 2025. Trend: 2023 $1,021 · 2024 $841 · 2025 $1,639
Food & beverage: $1,639
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $420 |
| Madrigal Pharmaceuticals | 4 | $316 |
| QOL Medical, LLC | 6 | $197 |
| Merck Sharp & Dohme LLC | 9 | $188 |
| THD America, Inc. | 1 | $183 |
| Exact Sciences Corporation | 4 | $108 |
| Janssen Biotech, Inc. | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: XIFAXAN, REZDIFFRA, Sucraid, ZERBAXA, Cologuard Collection Kit, TREMFYA, VOQUEZNA, PIFELTRO.
Industry payments across NY — which companies pay providers there.
